Kinaxis Inc. (TSE:KXS – Get Free Report) insider Mark Justin Morgan sold 3,000 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of C$172.25, for a total value of C$516,750.00. Following the transaction, the insider owned 10,299 shares of the company’s stock, valued at approximately C$1,774,002.75. The trade was a 22.56% decrease in their ownership of the stock.
Kinaxis Price Performance
Shares of TSE:KXS traded down C$1.52 on Wednesday, hitting C$169.22. The company’s stock had a trading volume of 65,898 shares, compared to its average volume of 122,506. The company has a 50-day simple moving average of C$158.22 and a 200 day simple moving average of C$145.34. Kinaxis Inc. has a 1 year low of C$117.22 and a 1 year high of C$201.00. The company has a market capitalization of C$4.60 billion, a PE ratio of 55.30, a PEG ratio of 3.60 and a beta of 0.76. The company has a debt-to-equity ratio of 11.14, a current ratio of 1.88 and a quick ratio of 2.29.
Kinaxis (TSE:KXS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C$1.08 EPS for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%.The company had revenue of C$230.64 million during the quarter. Sell-side analysts forecast that Kinaxis Inc. will post 4.2526231 EPS for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Analysis on KXS
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Featured Articles
- Five stocks we like better than Kinaxis
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
